Opioid overdose vs withdrawal: breathing, assessment and priorities

Use breathing and responsiveness as the first comparison

An unresponsive person with slow, shallow or absent breathing requires an emergency response. Opioid exposure may explain the pattern, particularly when supported by the history, but assessment should not wait for certainty about the substance. Pinpoint pupils can support suspicion; they are not a prerequisite for responding. Focus on effective ventilation and circulation rather than completing a symptom checklist first.

Withdrawal usually produces a different pattern: restlessness, yawning, tearing, sweating, muscle aches and gastrointestinal upset following reduction or interruption of regular opioid exposure. The patient may have a faster pulse and enlarged pupils. These features help organise the comparison, but no single finding establishes the diagnosis. Ask about the substance, last use, recent changes and any other medicines involved.

Respond to suspected overdose while obtaining more information

Activate emergency help, assess the airway and support breathing according to resuscitation training and the clinical protocol. Give available naloxone for suspected opioid overdose under the applicable instructions, while continuing the indicated breathing support or CPR. Waiting for a toxicology result or a complete medication history can delay a time-critical response. Delegate information gathering when another team member is available.

Record the observed respiratory pattern, responsiveness, interventions and response so the receiving team can follow the sequence. A person who cannot be awakened or who becomes cyanosed needs immediate attention even if the amount taken is unknown. For exam reasoning, an option focused on delayed counselling or routine admission paperwork does not address the immediate threat described in that presentation.

Continue assessment after naloxone changes the presentation

Naloxone can wear off before the opioid does, allowing respiratory depression to recur. Initial awakening is therefore not the endpoint of assessment. Continue observation and emergency evaluation, and follow the product instructions and treatment pathway if repeat administration is needed. Reassess ventilation and consciousness rather than assuming that a brief verbal response establishes sustained recovery from the overdose.

In a physically dependent person, naloxone can trigger abrupt withdrawal with agitation, vomiting, sweating and other distressing symptoms. Monitor the changing presentation and communicate what happened before and after reversal. Anticipating withdrawal does not justify delaying treatment of life-threatening respiratory depression. The immediate goal remains adequate breathing, followed by assessment and treatment of the problems that emerge during recovery.

Treat withdrawal as a clinical problem with a follow-up plan

Withdrawal deserves assessment of hydration, vomiting or diarrhoea, distress and coexisting illness. Use the locally approved assessment tool and prescribed treatment pathway. Avoid assuming every agitated patient is withdrawing: the history, observations and broader assessment must fit. A withdrawal score can help describe severity and track change, but it does not replace clinical judgement when the patient develops unexpected deterioration.

When opioid use disorder is present, withdrawal management alone is not the full treatment plan. Evidence-based care can include medicines such as buprenorphine or methadone, with selection and initiation managed by the treating clinician. Discuss overdose prevention and access to naloxone, and arrange continuing treatment support. Use neutral language that helps the patient disclose exposure and participate in care.

Compare two original opioid study scenarios

Imagine a hypothetical adult found difficult to awaken after suspected opioid use, breathing six times per minute. The options are to complete a withdrawal scale, initiate emergency assessment with breathing support and naloxone, or provide a quiet room and reassess later. The emergency option is strongest because inadequate breathing is the immediate danger; pupil size would not change that priority.

Now consider an awake patient who stopped regular opioid use and has yawning, sweating, abdominal cramps and diarrhoea, with adequate breathing. Assessment for withdrawal and the prescribed treatment plan better match this pattern than naloxone given solely for distress. If the first patient develops similar symptoms after reversal, recognise possible precipitated withdrawal while continuing respiratory surveillance. These are original teaching examples, not actual NCLEX questions.

Sources and further reading

SAMHSA: Opioid overdose prevention and reversal. Recognition of overdose and immediate emergency response with resuscitation and reversal medicine.

DailyMed: NARCAN prescribing information. Recurrent respiratory depression, continued surveillance and precipitated withdrawal.

HHS: Guide to reduction or discontinuation of long-term opioids. Physical dependence, withdrawal symptoms and risks of abrupt opioid interruption.

CDC: Treating opioid use disorder. Evidence-based medication treatment, limits of detoxification alone and naloxone education.